India’s First Dedicated Myeloma‑Lymphoma Centre Opens in Gurugram

In a ceremony that felt more like a celebration of hope than a routine ribbon‑cutting, the flagship hospital in Gurugram announced the launch of India’s first dedicated Myeloma‑Lymphoma Centre. The event, attended by health‑care leaders, government officials and a few families who have been waiting for such a facility, marked a turning point for cancer care in the country.

Why does this matter? Myeloma and lymphoma, though treatable, have historically been managed in fragmented ways—patients shuffled between haematology, radiology, surgery and palliative departments. The new centre brings all those specialties together under one roof, allowing a multidisciplinary team to chart a unified treatment roadmap from diagnosis to survivorship.

At the heart of the centre is a team of more than 30 experts—haematologists, medical oncologists, radiation oncologists, transplant surgeons, pathologists and supportive‑care nurses. "We wanted to break down silos," said Dr. Ananya Mehta, the centre’s medical director. "When a patient walks in, we immediately convene a tumour board. Decisions are made in minutes, not days, and every option—from conventional chemo to the latest CAR‑T therapy—is on the table."

Speaking of cutting‑edge, the facility is equipped with a state‑of‑the‑art apheresis unit for autologous stem‑cell collection, a dedicated clean‑room for manufacturing CAR‑T cells, and an advanced imaging suite that includes PET‑CT and MRI machines calibrated for haematologic malignancies. For many patients, especially those from tier‑2 and tier‑3 cities, this means access to world‑class treatment without having to travel abroad.

But the centre is more than just high‑tech equipment. It houses a robust research wing that collaborates with national institutes and global partners. Ongoing clinical trials are already recruiting, focusing on novel immunotherapies and precision‑medicine approaches that could, in time, shift the standard of care for Indian patients.

Patient stories are already emerging. Rahul Sharma, a 48‑year‑old accountant diagnosed with multiple myeloma last year, shared his experience: "I was scared when I heard ‘stem‑cell transplant’. The team walked me through every step, explained the risks, and even arranged counselling for my family. Today, I’m back at work and feeling hopeful for the first time in years."

The centre also emphasizes survivorship and quality‑of‑life programs—nutrition counseling, physiotherapy, psychosocial support and financial advisory services—all designed to address the long‑term challenges that accompany a cancer journey.

Looking ahead, the hospital plans to expand the centre’s capacity, add a dedicated pediatric haematology unit and launch a tele‑medicine portal to reach patients in remote corners of the nation. As Dr. Mehta summed up, "This is just the beginning. Our goal is to turn a diagnosis of myeloma or lymphoma from a story of dread into one of resilience and cure."